A senior executive at publishing giant Relx has admitted it has had conversations with investors about moving its listing to New York.
But Nick Luff, chief financial officer at the £72billion group, denied there were any imminent plans to relocate.
The US is one of the largest markets for a firm that provides products for lawyers, scientists, medical professionals and bankers.
It also owns medical journal The Lancet and an exhibitions arm, which runs book convention Comic Con.
Relx reported a pre-tax profit of £1.52billion for the first half, up from £1.45billion in 2024.
Sales rose 7 per cent to £4.7billion on the back of strong demand for products that use generative AI.
New York talks: Nick Luff (pictured), chief financial officer at £72bn publishing giant Relx, denied there were any imminent plans to relocate
DIY INVESTING PLATFORMS
AJ Bell
AJ Bell
Easy investing and ready-made portfolios
Hargreaves Lansdown
Hargreaves Lansdown
Free fund dealing and investment ideas
interactive investor
interactive investor
Flat-fee investing from £4.99 per month
InvestEngine
InvestEngine
Account and trading fee-free ETF investing
Trading 212
Trading 212
Free share dealing and no account fee
Affiliate links: If you take out a product This is Money may earn a commission. These deals are chosen by our editorial team, as we think they are worth highlighting. This does not affect our editorial independence.
This article was originally published by a www.dailymail.co.uk . Read the Original article here. .